Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrent AA Amyloidosis After Renal Transplantation: Effects on Allograft Survival

NCT02704065 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT02704065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02704065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrent AA Amyloidosis After Renal Transplantation: Effects on Allograft Survival
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
December 31, 2016
Enrollment
54 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aa amyloidosis